Distributing opioid overdose reversal medications (2SSB 5195)
2SSB 5195 helps to increase access to naloxone for all individuals at risk of an opioid overdose. The law requires hospital emergency departments (EDs) and many certified and licensed behavioral health settings to distribute prepackaged naloxone to individuals at risk of an opioid overdose.
On this page
Behavioral health agencies
Education materials
Please reference appendices J & K in the toolkits to locate translated versions of these educational materials.
- HCA official 2SSB 5195 harm reduction strategies and medications for opioid use disorder (MOUD).
- HCA official 2SSB 5195 overdose prevention and direction for naloxone use.
- Report to the Legislature on opioid overdose reversal medication bulk purchasing and distribution program.
Toolkits
- Emergency department (ED)
-
ED toolkit
ED appendicesÂ
- Appendix A. SB 5195 ED requirement summary
- Appendix B. Sample naloxone distribution policy
- Appendix C. Sample workflow quick sheet
- Appendix D. Sample smart phrases
- Appendix E. Sample staff training presentation
- Appendix F. Sample staff competency
- Appendix G. Sample distribution signature sheet
- Appendix H. Administrative FAQ
- Appendix I. Clinical staff FAQ
- Appendix J. Opioid overdose prevention and directions for Naloxone use (trifold brochure)Â (Includes alternate languages)
- Appendix K. Harm reduction strategies and MOUD (trifold brochure)Â (Includes alternate languages)
- Appendix L. Opioid overdose prevention and directions for Naloxone use (flat sheet)
- Appendix M. Harm reduction strategies and MOUD (flat sheet)
- Behavioral health agency (BHA)
-
BHA Toolkit
BHA appendices
- Appendix A. SB 5195 BHA requirement quick sheet
- Appendix B. Administrative FAQ
- Appendix C. Frontline staff FAQ
- Appendix D. Sample workflow
- Appendix E. Sample smart phrases
- Appendix F. Sample staff training presentation
- Appendix G. Sample staff competency sheet
- Appendix H. Sample distribution signature sheet
- Appendix I. Opioid overdose prevention and directions for Naloxone use (trifold brochure)Â (Includes alternate languages)
- Appendix J. Harm reduction strategies and MOUD (trifold brochure)Â (Includes alternate languages)
- Appendix K. Opioid overdose prevention and directions for Naloxone use (flat sheet)
- Appendix L. Harm reduction strategies and MOUD (flat sheet)
Webinars
- HCA Lunch and Learn series for behavioral health agencies (December 8)
- HCA Lunch and Learn series for behavioral health agencies (December 15)
Billing resources
Contact
For Medicaid billing and pharmacy questions
Email:Â Applehealthpharmacypolicy@hca.wa.gov
For assistance on billing for opioid reversal medication for uninsured clients
Email: HCANaloxoneReimbursement@hca.wa.gov
For training, consultation, educational materials, and implementation questions
Laura Meader, MA, LICSW
Overdose reversal medication program director
Email:Â laura.meader@hca.wa.gov